GSK6853
|
|
- CAS号:
- 1910124-24-1
- 英文名:
- GSK6853
- 英文别名:
- GSK6853;CS-2243;GSK-6853;GSK 6853;GSK6853 >=98% (HPLC);FQWDVNSBYDXPIO-CQSZACIVSA-N;BRPF1 bromodomain inhibitor GS6853;Inhibitor,inhibit,GSK6853,Epigenetic Reader Domain,GSK 6853,GSK-6853;N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide;(R)-N-(1,3-Dimethyl-6-(2-methylpiperazin-1-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide;Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy-
- 中文名:
- GSK6853
- 中文别名:
- 抑制剂GSK6853;GSK6853,BRPF1溴结构域抑制剂;BRPF1乙酰赖氨酸抑制剂(GSK6853);N-[2,3-二氢-1,3-二甲基-6-[(2R)-2-甲基-1-哌嗪基]-2-氧代-1H-苯并咪唑-5-基]-2-甲氧基苯甲酰胺;(R)-N-(1,3-二甲基-6-(2-甲基哌嗪-1-基)-2-氧代-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺
- CBNumber:
- CB73145989
- 分子式:
- C22H27N5O3
- 分子量:
- 409.48
- MOL File:
- 1910124-24-1.mol
|
|
|
GSK6853化学性质
-
沸点:
-
545.9±50.0 °C(Predicted)
-
|
-
密度:
-
1.247±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
Soluble in DMSO (25 mg/ml); ethanol (25 mg/ml)
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
13.03±0.20(Predicted)
-
|
-
颜色:
-
White
-
|
-
稳定性:
-
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
-
|
GSK6853性质、用途与生产工艺
GSK6853可用于制备溴域和PHD含指蛋白抑制剂的生物学研究。
GSK6853 是一个强的和有选择性的 RPF1 乙酰赖氨酸抑制剂 (pKd=9.5),它的选择性是其它的乙酰赖氨酸的 1600 倍。
The ip route of administration would be suitable for dosing GSK6853 in potential PK/PD models.
GSK6853
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/01/25 | HY-100220 | GSK6853 GSK6853 | 1910124-24-1 | 2mg | 500元 |
2024/01/25 | HY-100220 | GSK6853 GSK6853 | 1910124-24-1 | 5mg | 700元 |
1910124-24-1, GSK6853 相关搜索:
GSK2982772 GSK2636771 GSK3685032 FREEBASE N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 DO264 AZ20 泊马度胺 GSK8612 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 GSK8573 GSK8612 2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 GSK591(EPZ-015866) N/A / GSK872 N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
- API
- 药靶配体
- 医药研发中间体
- 活性小分子库
- 定制类
- 细胞生物学试剂
- GSK6853,BRPF1溴结构域抑制剂
- 抑制剂GSK6853
- (R)-N-(1,3-二甲基-6-(2-甲基哌嗪-1-基)-2-氧代-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺
- N-[2,3-二氢-1,3-二甲基-6-[(2R)-2-甲基-1-哌嗪基]-2-氧代-1H-苯并咪唑-5-基]-2-甲氧基苯甲酰胺
- BRPF1乙酰赖氨酸抑制剂(GSK6853)
- 1910124-24-1
- (R)-N-(1,3-Dimethyl-6-(2-methylpiperazin-1-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide
- Inhibitor,inhibit,GSK6853,Epigenetic Reader Domain,GSK 6853,GSK-6853
- GSK-6853;GSK 6853
- BRPF1 bromodomain inhibitor GS6853
- CS-2243
- N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide
- FQWDVNSBYDXPIO-CQSZACIVSA-N
- Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy-
- GSK6853 >=98% (HPLC)
- GSK6853